The spectra, symptom profiles and overlap of <scp>R</scp>ome <scp>III</scp> functional gastrointestinal disorders in a tertiary center in <scp>S</scp>outh <scp>C</scp>hina

Xiong, Liang; Shi, Quan; Gong, Xiao Rong; Chen, Yi; Chen, Min Hu

doi:10.1111/1751-2980.12178

Cited by 25 publications

(40 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…30 Although there is a limitation that the sample size is relatively small, the fact that overlap is common among FGIDs has also been reported in an Asian study. 27 Our study shows that patients with constipation frequently overlap with GERD, FD, or both. However, the patterns of overlaps are somewhat different from previous reports.…”

Section: Discussionmentioning

confidence: 59%

See 1 more Smart Citation

Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation

Park

Jee

Lee

et al. 2017

J Neurogastroenterol Motil

View full text Add to dashboard Cite

Background/AimsIn spite of increased concerns about the overlaps among the various functional gastrointestinal disorders (FGIDs), studies for the overlap between constipation and other common FGIDs are rare. Therefore, we investigated the patterns of overlaps between constipation and other common FGIDs. Methods This study was designed as a prospective nationwide multi-center questionnaire study using Rome III questionnaires for functional dyspepsia (FD), irritable bowel syndrome (IBS), and functional constipation (FC), as well as various questionnaires about patients' information, degree of symptoms, and quality of life. For the evaluation of gastroesophageal reflux disease (GERD), GERD-Q was used. Results From 19 centers, 759 patients with constipation were enrolled. The proportions of FC and IBS subtypes of constipation (IBS-C) were 59.4% and 40.6%, respectively. Among them, 492 (64.8%) showed no overlap. One hundred and thirty-six patients (17.9%) presented overlapping GERD, and 80 patients (10.5%) presented overlapping FD. Fifty one (6.7%) of patients were overlapped by both GERD and FD. Coincidental herniated nucleus pulposus (HNP) (P = 0.026) or pulmonary diseases (P = 0.034), reduced fiber intake (P = 0.013), and laxative use (P < 0.001) independently affected the rate of overlaps. These overlapping conditions negatively affected the constipation-associated quality of life, general quality of life, and degree of constipation. ConclusionsThe overlap of GERD or FD was common in patients with constipation. Coincidental HNP or pulmonary diseases, reduced fiber intake, and laxatives use were found to be independent associated factors for overlapping common FGIDs in Korean patients with constipation.

show abstract

Section: Discussionmentioning

confidence: 59%

“…There have been several original or review reports on the overlap of these FGIDs, particularly among common FGIDs such as FD, symptomatic GERD, and IBS. [3][4][5][6][7][8]10,11,[27][28][29] According to a review article conducted by Fujiwara and Arakawa, 5 up to 15.8% of the general population and 62.3%…”

Section: Discussionmentioning

confidence: 99%

Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation

Park

Jee

Lee

et al. 2017

J Neurogastroenterol Motil

View full text Add to dashboard Cite

show abstract

“…We also used four screening questions to screen patients for IBS: “In the last three months, did you have pain or other discomfort anywhere in your abdomen?”, “Did this pain or discomfort happen close in time to a bowel movement ‐ just before, during or soon after?”, “Did your stools become either softer or harder than usual when you had this pain or discomfort?” and “Did your stools become either more frequent or less frequent than usual when you had this pain or discomfort?” Patients who answered yes to the first question and at least one of the last three questions were further interviewed regarding abdominal symptoms and defecation symptoms. In China, patients can accurately express a sense of bloating, and we identified a high proportion of patients with bloating . Therefore, we divided abdominal symptoms into pain, bloating and other discomfort.…”

Section: Methodsmentioning

confidence: 99%

Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross‐sectional survey

Bai

Xia

Jiang

et al. 2017

J of Gastro and Hepatol

View full text Add to dashboard Cite

945 Gastrointestinal: Enema nozzle injury to the rectum, a vague presentation with significant morbidity 946 Gastrointestinal: Gastric perforation during esophageal endoscopic submucosal dissection: A serious adverse event in a patient with esophageal stricture 947 Gastrointestinal: Idiopathic granulomatous gastritis observed by magnifying narrow-band imaging endoscopy 948 Hepatobiliary and Pancreatic: Unusual cause of acute pancreatitis 949 Gastrointestinal: Severe congestive heart failure and acute gastric mucosal necrosis Meta Analysis and Systematic Reviews 950 Systematic review: Current evidence in non-alcoholic fatty liver disease lacks relevance to patients with advanced fibrosis R Parker, J Hodson and IAC Rowe 957 Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis YS Jung, Reviews 966 Urgency to treat patients with chronic hepatitis C Clinical Gastroenterology 992 Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus A Loktionov, V Chhaya, T Bandaletova and A Poullis 1003 Identifying the optimal strategy for screening of advanced colorectal neoplasia YS Jung, 1026 Do surveillance intervals in patients with more than five adenomas at index colonoscopy be shorter than those in patients with three to four adenomas? A Korean Association for the Study of Intestinal Experimental Gastroenterology 1040 Effects of argon plasma coagulation on human stomach tissue: An ex vivo study EJ Gong, Endoscopy 1046 Probe-based confocal laser endomicroscopy in the margin delineation of early gastric cancer for endoscopic submucosal dissection JC

show abstract

“…Moreover, IBS is a common reason for gastroenterology consultation in clinical practice [2]. IBS is associated with substantial morbidity, loss of working hours, loss of productivity, impairment of quality of life, and economic burden on healthcare services [3].…”

Section: Introductionmentioning

confidence: 99%

“…Patients with SIBO allocated to nor-P = NS). Although norfloxacin was more effective in reducing symptom score at 1 month among patients with SIBO than those without [15/80, 19% on culture, four on GHBT too; 6.5 (2-13) vs. 2 (0-10), P = 0.01; 8.5(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16) vs. 5 (0-12), P < 0.001] but not placebo, the scores were comparable at 6 months [3 (1-10) vs. 9(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19); P = NS]. At 1 month of follow-up, SIBO patients had symptom resolution that turned Rome III negative more…”

mentioning

confidence: 99%

A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth

Ghoshal

Srivastava

Misra

et al. 2016

European Journal of Gastroenterology & Hepatology

View full text Add to dashboard Cite

show abstract

The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China

Abstract: This study provided the detailed spectra and symptom profiles for all FGID. Overlapping FGID are common in China.

Cited by 25 publications

References 18 publications

Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation

Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation

Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross‐sectional survey

A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth

Contact Info

Product

Resources

About